Skip to Content

Walgreens Boots Alliance Inc WBA

Morningstar Rating
$21.26 +0.10 (0.47%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

WBA is trading at a 36% discount.
Price
$21.26
Fair Value
$67.00
Uncertainty
High
1-Star Price
$96.96
5-Star Price
$83.20
Economic Moat
Rjvm
Capital Allocation
Byvnqwwb

Bulls Say, Bears Say

Bulls

Walgreens is one of the largest domestic retail pharmacy chains, with around 8,800 U.S. locations. Over three fourths of Americans live within five miles of a Walgreens location.

Bears

The confluence of reimbursement pricing pressure in the retail pharmacy and tough general retail store conditions has diminished profitability and ROICs.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if WBA is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$21.16
Day Range
$21.0621.40
52-Week Range
$19.6836.58
Bid/Ask
$21.26 / $21.34
Market Cap
$18.33 Bil
Volume/Avg
717 / 13.9 Mil

Key Statistics

Price/Earnings (Normalized)
6.09
Price/Sales
0.13
Dividend Yield (Trailing)
7.95%
Dividend Yield (Forward)
4.70%
Total Yield
8.33%

Company Profile

Walgreens Boots Alliance is one of the largest retail pharmacy chains in the U.S., with over 8,500 locations. Nearly three quarters of Americans live within five miles of a Walgreens location. Roughly two thirds of revenue is generated from prescription drug sales; Walgreens makes up 20% of total prescription revenue in the U.S. Walgreens also generates sales from retail products (general wellness consumables and its own branded merchandise), European drug wholesale, and healthcare. With more locations incorporating additional services like Health Corner and Village Medical, Walgreens creates an omnichannel experience for patients and positions itself as a one-stop healthcare provider.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Mid Value
Total Number of Employees
331,000

Competitors

Valuation

Metric
WBA
WMT
DG
Price/Earnings (Normalized)
6.098.9516.72
Price/Book Value
0.945.644.94
Price/Sales
0.130.730.82
Price/Cash Flow
16.9114.0710.03
Price/Earnings
WBA
WMT
DG

Financial Strength

Metric
WBA
WMT
DG
Quick Ratio
0.260.200.08
Current Ratio
0.660.851.22
Interest Coverage
0.119.758.63
Quick Ratio
WBA
WMT
DG

Profitability

Metric
WBA
WMT
DG
Return on Assets (Normalized)
3.09%6.56%6.59%
Return on Equity (Normalized)
14.69%21.56%32.35%
Return on Invested Capital (Normalized)
5.45%12.12%9.34%
Return on Assets
WBA
WMT
DG
See how this stock stacks up to its competitors with Morningstar Investor

Pharmaceutical Retailers Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
RADLY
Raia Drogasil SA ADRRrjvnb$9.2 Bil
ALBHF
Alibaba Health Information Technology LtdCkmzn$7.1 Bil
ALBBY
Alibaba Health Information Technology Ltd ADRSsfpwz$7.1 Bil
MSMKF
MatsukiyoCocokara & CoQsqbd$6.9 Bil
WLCGF
Welcia Holdings Co LtdWlpxmzj$3.9 Bil
CLCGY
Clicks Group Ltd ADRJmpjnv$3.7 Bil
TSUSF
Tsuruha Holdings IncPfhc$3.6 Bil
SGIPF
Sugi Holdings Co LtdXnvj$2.8 Bil
SHPPF
Redcare Pharmacy NVVdrlk$2.8 Bil

Sponsor Center